1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Global Continuous Subcutaneous Insulin Infusion Market – Introduction
4.1 What is a Continuous Subcutaneous Insulin Infusion
4.2 Industry Trends
4.3 Competitive Intelligence
5 Global Continuous Subcutaneous Insulin Infusion Market Landscape
5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)
6 Global Continuous Subcutaneous Insulin Infusion Market - Breakup by Product
6.1 Patch Pumps
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2019-2024)
6.1.3 Market Forecast (2025-2033)
6.1.4 Market Segmentation
6.1.4.1 Basal
6.1.4.2 Bolus
6.1.4.3 Basal and Bolus
6.1.5 Market Breakup by Patient Type
6.1.6 Market Breakup by End Use
6.2 Tethered Pumps
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2019-2024)
6.2.3 Market Forecast (2025-2033)
6.2.4 Market Segmentation
6.2.4.1 Insulin Reservoir or Cartridges
6.2.4.2 Insulin Set Insertion Devices
6.2.4.3 Battery
6.2.5 Market Breakup by Patient Type
6.2.6 Market Breakup by End Use
6.3 Attractive Investment Proposition by Product
7 Global Continuous Subcutaneous Insulin Infusion Market - Breakup by Patient Type
7.1 Diabetes Type 1
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2019-2024)
7.1.3 Market Forecast (2025-2033)
7.1.4 Market Breakup by Product
7.1.5 Market Breakup by End Use
7.2 Diabetes Type 2
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2019-2024)
7.2.3 Market Forecast (2025-2033)
7.2.4 Market Breakup by Product
7.2.5 Market Breakup by End Use
7.3 Attractive Investment Proposition by Patient Type
8 Global Continuous Subcutaneous Insulin Infusion Market - Breakup by End Use
8.1 Hospitals and Clinics
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2019-2024)
8.1.3 Market Forecast (2025-2033)
8.1.4 Market Breakup by Product
8.1.5 Market Breakup by Patient Type
8.2 Homecare
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2019-2024)
8.2.3 Market Forecast (2025-2033)
8.2.4 Market Breakup by Product
8.2.5 Market Breakup by Patient Type
8.3 Laboratories
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2019-2024)
8.3.3 Market Forecast (2025-2033)
8.3.4 Market Breakup by Product
8.3.5 Market Breakup by Patient Type
8.4 Attractive Investment Proposition by End Use
9 Global Continuous Subcutaneous Insulin Infusion Market – Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Drivers
9.1.1.2 Historical and Current Market Trends (2019-2024)
9.1.1.3 Market Breakup by Product
9.1.1.4 Market Breakup by Patient Type
9.1.1.5 Market Breakup by End Use
9.1.1.6 Key Players
9.1.1.7 Market Forecast (2025-2033)
9.1.2 Canada
9.1.2.1 Market Drivers
9.1.2.2 Historical and Current Market Trends (2019-2024)
9.1.2.3 Market Breakup by Product
9.1.2.4 Market Breakup by Patient Type
9.1.2.5 Market Breakup by End Use
9.1.2.6 Key Players
9.1.2.7 Market Forecast (2025-2033)
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Drivers
9.2.1.2 Historical and Current Market Trends (2019-2024)
9.2.1.3 Market Breakup by Product
9.2.1.4 Market Breakup by Patient Type
9.2.1.5 Market Breakup by End Use
9.2.1.6 Key Players
9.2.1.7 Market Forecast (2025-2033)
9.2.2 Japan
9.2.2.1 Market Drivers
9.2.2.2 Historical and Current Market Trends (2019-2024)
9.2.2.3 Market Breakup by Product
9.2.2.4 Market Breakup by Patient Type
9.2.2.5 Market Breakup by End Use
9.2.2.6 Key Players
9.2.2.7 Market Forecast (2025-2033)
9.2.3 India
9.2.3.1 Market Drivers
9.2.3.2 Historical and Current Market Trends (2019-2024)
9.2.3.3 Market Breakup by Product
9.2.3.4 Market Breakup by Patient Type
9.2.3.5 Market Breakup by End Use
9.2.3.6 Key Players
9.2.3.7 Market Forecast (2025-2033)
9.2.4 South Korea
9.2.4.1 Market Drivers
9.2.4.2 Historical and Current Market Trends (2019-2024)
9.2.4.3 Market Breakup by Product
9.2.4.4 Market Breakup by Patient Type
9.2.4.5 Market Breakup by End Use
9.2.4.6 Key Players
9.2.4.7 Market Forecast (2025-2033)
9.2.5 Australia
9.2.5.1 Market Drivers
9.2.5.2 Historical and Current Market Trends (2019-2024)
9.2.5.3 Market Breakup by Product
9.2.5.4 Market Breakup by Patient Type
9.2.5.5 Market Breakup by End Use
9.2.5.6 Key Players
9.2.5.7 Market Forecast (2025-2033)
9.2.6 Indonesia
9.2.6.1 Market Drivers
9.2.6.2 Historical and Current Market Trends (2019-2024)
9.2.6.3 Market Breakup by Product
9.2.6.4 Market Breakup by Patient Type
9.2.6.5 Market Breakup by End Use
9.2.6.6 Key Players
9.2.6.7 Market Forecast (2025-2033)
9.2.7 Others
9.2.7.1 Historical and Current Market Trends (2019-2024)
9.2.7.2 Market Forecast (2025-2033)
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Drivers
9.3.1.2 Historical and Current Market Trends (2019-2024)
9.3.1.3 Market Breakup by Product
9.3.1.4 Market Breakup by Patient Type
9.3.1.5 Market Breakup by End Use
9.3.1.6 Key Players
9.3.1.7 Market Forecast (2025-2033)
9.3.2 France
9.3.2.1 Market Drivers
9.3.2.2 Historical and Current Market Trends (2019-2024)
9.3.2.3 Market Breakup by Product
9.3.2.4 Market Breakup by Patient Type
9.3.2.5 Market Breakup by End Use
9.3.2.6 Key Players
9.3.2.7 Market Forecast (2025-2033)
9.3.3 United Kingdom
9.3.3.1 Market Drivers
9.3.3.2 Historical and Current Market Trends (2019-2024)
9.3.3.3 Market Breakup by Product
9.3.3.4 Market Breakup by Patient Type
9.3.3.5 Market Breakup by End Use
9.3.3.6 Key Players
9.3.3.7 Market Forecast (2025-2033)
9.3.4 Italy
9.3.4.1 Market Drivers
9.3.4.2 Historical and Current Market Trends (2019-2024)
9.3.4.3 Market Breakup by Product
9.3.4.4 Market Breakup by Patient Type
9.3.4.5 Market Breakup by End Use
9.3.4.6 Key Players
9.3.4.7 Market Forecast (2025-2033)
9.3.5 Spain
9.3.5.1 Market Drivers
9.3.5.2 Historical and Current Market Trends (2019-2024)
9.3.5.3 Market Breakup by Product
9.3.5.4 Market Breakup by Patient Type
9.3.5.5 Market Breakup by End Use
9.3.5.6 Key Players
9.3.5.7 Market Forecast (2025-2033)
9.3.6 Others
9.3.6.1 Historical and Current Market Trends (2019-2024)
9.3.6.2 Market Forecast (2025-2033)
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Drivers
9.4.1.2 Historical and Current Market Trends (2019-2024)
9.4.1.3 Market Breakup by Product
9.4.1.4 Market Breakup by Patient Type
9.4.1.5 Market Breakup by End Use
9.4.1.6 Key Players
9.4.1.7 Market Forecast (2025-2033)
9.4.2 Mexico
9.4.2.1 Market Drivers
9.4.2.2 Historical and Current Market Trends (2019-2024)
9.4.2.3 Market Breakup by Product
9.4.2.4 Market Breakup by Patient Type
9.4.2.5 Market Breakup by End Use
9.4.2.6 Key Players
9.4.2.7 Market Forecast (2025-2033)
9.4.3 Others
9.4.3.1 Historical and Current Market Trends (2019-2024)
9.4.3.2 Market Forecast (2025-2033)
9.5 Middle East
9.5.1 Market Drivers
9.5.2 Historical and Current Market Trends (2019-2024)
9.5.3 Market Breakup by Product
9.5.4 Market Breakup by Patient Type
9.5.5 Market Breakup by End Use
9.5.6 Market Breakup by Country
9.5.7 Key Players
9.5.8 Market Forecast (2025-2033)
9.6 Africa
9.6.1 Market Drivers
9.6.2 Historical and Current Market Trends (2019-2024)
9.6.3 Market Breakup by Product
9.6.4 Market Breakup by Patient Type
9.6.5 Market Breakup by End Use
9.6.6 Market Breakup by Country
9.6.7 Key Players
9.6.8 Market Forecast (2025-2033)
9.7 Attractive Investment Proposition by Region
10 Market Dynamics
10.1 Market Driving Factors
10.2 Market Restraining Factors
10.3 Market Opportunities
11 Key Technological Trends & Development
12 Government Regulations and Strategies
13 Recent Industry News
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Value Chain Analysis
16 Global Continuous Subcutaneous Insulin Infusion Market – Competitive Landscape
16.1 Overview
16.2 Market Structure
16.3 Market Share by Key Players
16.4 Market Player Positioning
16.5 Top Winning Strategies
16.6 Competitive Dashboard
16.7 Company Evaluation Quadrant
17 Competitive Landscape
17.1 B. Braun SE
17.1.1 Business Overview
17.1.2 Products Offered
17.1.3 Business Strategies
17.1.4 SWOT Analysis
17.1.5 Major News and Events
17.2 F. Hoffmann-La Roche Ltd
17.2.1 Business Overview
17.2.2 Products Offered
17.2.3 Business Strategies
17.2.4 SWOT Analysis
17.2.5 Major News and Events
17.3 Insulet Corporation
17.3.1 Business Overview
17.3.2 Products Offered
17.3.3 Business Strategies
17.3.4 SWOT Analysis
17.3.5 Major News and Events
17.4 Medtronic plc
17.4.1 Business Overview
17.4.2 Products Offered
17.4.3 Business Strategies
17.4.4 SWOT Analysis
17.4.5 Major News and Events
17.5 Ypsomed
17.5.1 Business Overview
17.5.2 Products Offered
17.5.3 Business Strategies
17.5.4 SWOT Analysis
17.5.5 Major News and Events
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
18 Strategic Recommendations
19 Appendix